Hints and tips:
Showing results for JANSSEN PHARMACEUTICA, INC.
...Janssen is the pharmaceutical division of J&J....
FDA will now weigh whether to allow use of first single-dose jab to prevent the virus
...The deal between J&J's Janssen Pharmaceutica and the AU's African Vaccine Acquisition Trust can be expanded to an extra 180m doses in 2022....
...Not only was the BioNTech/Pfizer vaccine the first to be deployed but it has suffered less from rare side effects and manufacturing glitches than its big western rivals Oxford/AstraZeneca, Janssen or Moderna...
...Mathai Mammen, global head of Janssen Research & Development at Johnson & Johnson, said the company looked forward to “discussing with public health officials a potential strategy for our Johnson & Johnson...
...“The Janssen vaccine will be another weapon in our arsenal to beat this pandemic,” said vaccines minister Nadhim Zahawi....
...The deal will give J&J’s drugmaking division Janssen Pharmaceutica access to Momenta’s pipeline of products, including nipocalimab, a promising treatment for the rare muscular disease myasthenia gravis that...
..., J&J’s pharmaceutical division, told the panel on Friday: “Janssen’s vaccine candidate would play a critical role in the global efforts to fight Covid-19 . . ....
...“At present, no clear causal relationship has been established between these rare events and the Janssen [J&J] Covid-19 vaccine,” it said, adding that it was working closely with experts and regulators to...
...J&J is preparing to test a new formulation that could be targeted at the 501.v2 variant, but Mathai Mammen, global head of research and development for Janssen, J&J’s pharmaceuticals division, said he was...
...Through its Janssen subsidiary, the New Jersey-based drugmaker will administer its experimental vaccine to 6,000 UK volunteers in two doses in a phase-3 trial....
...Lockdowns may have helped prepare the ground for that switch, which according to EQT dealmaker Bert Janssens has so far happened more slowly in southern Europe where Idealista operates than it has in Britain...
...He joined Janssen, J&J’s pharma division, in sales in 1988, with only a BA in biology....
...“Not once did the state identify a single Oklahoma doctor who was misled by a single Janssen statement, nor did it prove that Janssen misleadingly marketed opioids or caused any harm in Oklahoma,” Mr Sparks...
...Pharmaceutica, Johnson & Johnson’s Belgian-based drugmaker....
...Mathai Mammen, global head of Janssen Research and Development, a subsidiary of Johnson & Johnson, said Spravato was a “unique and innovative medicine” that had the potential to offer “new hope” to the third...
...Mr Rouse acknowledges that, Janssen’s enthusiasm aside, other companies have been less convinced of the advantages of outcomes-based pricing....
GSK and MSD among 25 companies included in government’s £1bn ‘sector deal’
...It added: “Janssen discovers and develops medical innovations to save and enhance lives....
...In a statement on Wednesday, Scott White, president at Janssen Biotech, a pharmaceuticals unit of J&J, said: “We are effectively competing on value and price and to date, Pfizer has failed to demonstrate...
.... ©2018 Nikkei Inc. All rights reserved....
...Johan Van Hoof, head of infectious diseases and vaccines at Janssen, part of the Johnson & Johnson pharmaceuticals group, says he also has cause for optimism....
...A European distribution centre opened in 2012 by Janssen Pharmaceutica (part of the multinational Johnson & Johnson) met all of the criteria set by the regional government and received €11m out of a total...
...One team is a collaboration between the Scripps Research Institute in California and the Janssen Prevention Centre in the Netherlands, part of the Johnson and Johnson pharmaceutical group; the other is at...
...Shares of Isis Pharmaceuticals gained nearly 11 per cent to $69.19, after the company announced a collaboration with Janssen Biotech, a subsidiary of Johnson & Johnson, to develop drugs to treat autoimmune...
International Edition